(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Hyperglycemia D006943 21 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Reperfusion Injury D015427 65 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Cattle Diseases D002418 24 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Karimian Azari E et al. Possible role of intestinal fatty acid oxidation in the eating-inhibitory effect of the PPAR-α agonist Wy-14643 in high-fat diet fed rats. 2013 PLoS ONE pmid:24069361
McArt JA et al. Elevated non-esterified fatty acids and β-hydroxybutyrate and their association with transition dairy cow performance. 2013 Vet. J. pmid:24054909
Matković M et al. Synthesis of novel adamantyl and homoadamantyl-substituted β-hydroxybutyric acids. 2013 Mol. Divers. pmid:24043584
Zebeli Q et al. Intermittently-induced endotoxaemia has no effect on post-challenge plasma metabolites, but increases body temperature and cortisol concentrations in periparturient dairy cows. 2013 Res. Vet. Sci. pmid:23911054
Sørensen LK et al. Simultaneous determination of β-hydroxybutyrate and β-hydroxy-β-methylbutyrate in human whole blood using hydrophilic interaction liquid chromatography electrospray tandem mass spectrometry. 2013 Clin. Biochem. pmid:23994603
Laird MD et al. Augmentation of normal and glutamate-impaired neuronal respiratory capacity by exogenous alternative biofuels. 2013 Transl Stroke Res pmid:24323418
Yuan K et al. TNFα altered inflammatory responses, impaired health and productivity, but did not affect glucose or lipid metabolism in early-lactation dairy cows. 2013 PLoS ONE pmid:24260367
Mulliniks JT et al. Does β-hydroxybutyrate concentration influence conception date in young postpartum range beef cows? 2013 J. Anim. Sci. pmid:23478827
Murata Y et al. Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet. 2013 PLoS ONE pmid:23874946
Hornig KJ et al. Evaluation of a point-of-care glucose and β-hydroxybutyrate meter operated in various environmental conditions in prepartum and postpartum sheep. 2013 Am. J. Vet. Res. pmid:23879842
Fanos V et al. Urinary metabolomics in newborns infected by human cytomegalovirus: a preliminary investigation. 2013 Early Hum. Dev. pmid:23809353
Ospina PA et al. Using nonesterified fatty acids and β-hydroxybutyrate concentrations during the transition period for herd-level monitoring of increased risk of disease and decreased reproductive and milking performance. 2013 Vet. Clin. North Am. Food Anim. Pract. pmid:23809897
Wang B et al. Engineering cyanobacteria for photosynthetic production of 3-hydroxybutyrate directly from CO2. 2013 Metab. Eng. pmid:23333586
El-Deeb WM Clinicobiochemical investigations of gangrenous mastitis in does: immunological responses and oxidative stress biomarkers. 2013 J Zhejiang Univ Sci B pmid:23303629
Xu J et al. Metabolomic profilings of urine and serum from high fat-fed rats via 1H NMR spectroscopy and pattern recognition. 2013 Appl. Biochem. Biotechnol. pmid:23306893
Sassone-Corsi P Physiology. When metabolism and epigenetics converge. 2013 Science pmid:23307727
Moyes KM et al. Identification of hepatic biomarkers for physiological imbalance of dairy cows in early and mid lactation using proteomic technology. 2013 J. Dairy Sci. pmid:23548295
Zhang Y et al. 1H NMR-based spectroscopy detects metabolic alterations in serum of patients with early-stage ulcerative colitis. 2013 Biochem. Biophys. Res. Commun. pmid:23510994
Hughes TE et al. Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women. 2013 Obesity (Silver Spring) pmid:23512440
Haviland JA et al. NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment. 2013 Obesity (Silver Spring) pmid:23512955